knowledge -WSS

knowledge

author：entertainment 2025-09-27 16:48:26 - browse：83676

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： A Q&A with Aletha Maybank, AMA’s chief health equity officer

WSS

Obesity now affects over 1 billion people worldwide, study finds

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Flu vaccine offering decent levels of protection this winter, new data show

Emergency medicine has repudiated 'excited delirium.' Now what?

How to address the problem of discarded donor organs

focus

knowledge

entertainment

Hollywood unions extend contract negotiations for actors

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Medical leaders decry Supreme Court decision on affirmative action

Paying for Covid pills will soon shift to insurers

Hollywood unions extend contract negotiations for actors

Maker of FluMist seeks to allow at

Walensky prepares to leave CDC — and Congress — behind

Senate panel to vote on hospitals, PBMs, prisoner care

Dobbs anniversary: the lost opportunity of abortion as health care

Chimpanzees, like humans and whales, get menopause: Study

hotspot

How to address the problem of discarded donor organs

Chimpanzees, like humans and whales, get menopause: Study

Change Healthcare cyberattack outage could last weeks

Why getting cancer drugs just got harder for rural patients

Readout Newsletter: XBI biotech index, Akero Therapeutics

Senate panel to vote on hospitals, PBMs, prisoner care

hotspot

knowledge

leisure time

hotspot